Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Abstract

Optimization of the potency and duration of action of N-hydroxyurea 5-lipoxygenase inhibitors.

R L Bell, J B Bouska, P E Malo, C Lanni, R R Harris, E R Otis, A O Stewart, D W Brooks and G W Carter
Journal of Pharmacology and Experimental Therapeutics February 1995, 272 (2) 724-731;
R L Bell
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J B Bouska
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
P E Malo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C Lanni
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R R Harris
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E R Otis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A O Stewart
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D W Brooks
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
G W Carter
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 272 no. 2 724-731
PubMed 
7853186

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Published online February 1, 1995.


Author Information

  1. R L Bell,
  2. J B Bouska,
  3. P E Malo,
  4. C Lanni,
  5. R R Harris,
  6. E R Otis,
  7. A O Stewart,
  8. D W Brooks and
  9. G W Carter
  1. Immunosciences Research Area, Abbott Laboratories, Abbott Park, Illinois.

Statistics from Altmetric.com

Article usage

Article usage: February 1999 to December 2023

AbstractFullPdf
Feb 1999200
Apr 1999100
Jul 1999200
Nov 1999100
Apr 2000100
May 2000600
Jun 2000100
Jul 2000100
Aug 2000100
Jan 2001300
May 2001400
Jul 2001100
Aug 2001100
Sep 2001100
Jan 2002100
Mar 2002100
Jul 2002100
Aug 2002100
Dec 2002100
Apr 2003400
May 2003200
Jun 2003100
Jul 2003400
Aug 2003200
Sep 2003800
Oct 2003600
Nov 2003400
Dec 2003500
Jan 2004800
Feb 2004500
Mar 2004400
Apr 2004400
May 2004700
Jun 20041200
Jul 20041800
Aug 20041900
Sep 20041400
Oct 20041400
Nov 20041500
Dec 20041700
Jan 20052100
Feb 2005600
Mar 2005800
Apr 2005800
May 2005800
Jun 2005900
Jul 2005900
Aug 2005700
Sep 2005300
Oct 2005500
Nov 2005500
Dec 2005700
Jan 2006100
Feb 2006700
Mar 2006401
Apr 2006504
May 2006500
Jun 2006600
Jul 2006302
Aug 2006203
Sep 2006002
Oct 2006303
Nov 2006402
Dec 20064016
Feb 2007200
Mar 2007001
Apr 2007201
May 2007406
Jun 2007303
Jul 2007001
Aug 2007400
Sep 2007201
Oct 2007103
Nov 2007400
Dec 2007400
Jan 2008001
Feb 2008304
Mar 2008500
Apr 2008300
May 2008303
Jun 2008501
Jul 2008301
Aug 2008102
Sep 2008301
Oct 2008603
Nov 2008801
Dec 2008403
Jan 2009305
Feb 2009602
Mar 2009301
Apr 2009300
May 2009003
Jun 2009202
Jul 2009204
Aug 2009101
Sep 2009504
Oct 2009601
Nov 2009400
Dec 2009600
Jan 2010200
Feb 2010707
Mar 2010303
Apr 2010603
May 2010400
Jun 2010300
Jul 2010200
Aug 2010702
Sep 2010200
Oct 2010305
Nov 2010202
Dec 2010203
Jan 2011501
Feb 2011600
Mar 2011302
Apr 2011300
May 2011401
Jun 2011701
Jul 2011300
Aug 2011601
Sep 2011201
Oct 20111302
Nov 2011801
Dec 2011501
Jan 2012504
Feb 2012700
Mar 2012500
Apr 2012500
May 2012700
Jun 2012401
Jul 20121001
Aug 2012701
Sep 2012600
Oct 20121000
Nov 2012402
Dec 2012300
Jan 2013501
Feb 2013400
Mar 2013403
Apr 2013800
May 2013400
Jun 2013404
Jul 2013200
Aug 2013100
Sep 20131203
Oct 2013100
Nov 2013301
Dec 2013400
Jan 2014202
Feb 2014302
Mar 2014501
Apr 20141001
May 2014101
Jun 2014202
Jul 2014300
Sep 2014201
Oct 2014600
Nov 20141002
Dec 2014401
Feb 20151401
Mar 2015200
Apr 2015302
Jun 2015500
Jul 2015302
Aug 2015300
Sep 2015400
Nov 2015102
Jan 2016600
Feb 2016801
Mar 2016500
Apr 2016200
May 2016401
Jun 2016601
Jul 2016501
Sep 2016200
Oct 2016702
Nov 20161602
Dec 2016703
Jan 2017100
Feb 20171101
Mar 2017601
Apr 2017901
May 2017900
Jun 2017301
Jul 2017101
Aug 20171105
Sep 2017301
Oct 2017600
Nov 2017401
Dec 2017700
Jan 2018400
Feb 2018900
Mar 20181202
Apr 20181000
May 2018100
Jun 2018300
Jul 2018201
Aug 2018501
Sep 2018400
Oct 2018301
Nov 2018500
Dec 2018100
Jan 2019701
Feb 2019100
Mar 2019300
Apr 2019400
May 2019100
Jun 2019004
Jul 2019100
Aug 2019100
Sep 2019502
Oct 2019603
Nov 2019800
Dec 2019702
Jan 2020301
Feb 2020300
Mar 2020101
Apr 2020100
Jul 2020101
Aug 2020600
Sep 2020501
Oct 20201400
Nov 2020501
Dec 2020900
Jan 20212005
Feb 2021800
Mar 2021300
Apr 2021400
May 2021200
Jun 2021700
Jul 2021600
Aug 2021600
Sep 2021200
Oct 2021300
Nov 20211400
Dec 20211600
Jan 2022401
Feb 2022600
Mar 2022200
Apr 2022900
May 2022200
Jun 2022700
Jul 20221500
Aug 2022400
Sep 20221201
Oct 2022200
Nov 2022500
Dec 2022900
Jan 2023300
Feb 2023300
Mar 20231200
Apr 2023600
May 2023800
Jun 2023700
Jul 2023800
Aug 2023700
Sep 2023300
Oct 20231100
Nov 2023300
Dec 2023200

PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 272, Issue 2
1 Feb 1995
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Optimization of the potency and duration of action of N-hydroxyurea 5-lipoxygenase inhibitors.
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Abstract

Optimization of the potency and duration of action of N-hydroxyurea 5-lipoxygenase inhibitors.

R L Bell, J B Bouska, P E Malo, C Lanni, R R Harris, E R Otis, A O Stewart, D W Brooks and G W Carter
Journal of Pharmacology and Experimental Therapeutics February 1, 1995, 272 (2) 724-731;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Abstract

Optimization of the potency and duration of action of N-hydroxyurea 5-lipoxygenase inhibitors.

R L Bell, J B Bouska, P E Malo, C Lanni, R R Harris, E R Otis, A O Stewart, D W Brooks and G W Carter
Journal of Pharmacology and Experimental Therapeutics February 1, 1995, 272 (2) 724-731;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics